Bausch Health Companies INC. 8-K Filing
Ticker: BHC · Form: 8-K · Filed: Dec 23, 2025 · CIK: 885590
Sentiment: neutral
Filing Stats: 574 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-12-23 17:27:35
Key Financial Figures
- $1.6 billion — Senior Secured Notes due 2028 for up to $1.6 billion aggregate principal amount of new 10.00
Filing Documents
- bhc-20251223.htm (8-K) — 29KB
- exhibit991finalresultsexpi.htm (EX-99.1) — 20KB
- image_0.jpg (GRAPHIC) — 4KB
- 0000885590-25-000057.txt ( ) — 176KB
- bhc-20251223.xsd (EX-101.SCH) — 2KB
- bhc-20251223_lab.xml (EX-101.LAB) — 22KB
- bhc-20251223_pre.xml (EX-101.PRE) — 13KB
- bhc-20251223_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events On December 23, 2025, Bausch Health Companies Inc. (the "Company") announced the final results and expiration, as of 5:00 p.m., New York City time, on December 23, 2025, of its previously announced offers to exchange the Company's outstanding 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due 2028 for up to $1.6 billion aggregate principal amount of new 10.00% Senior Secured Notes due 2032 (the "Offers") to be issued by the Company's indirect wholly-owned subsidiary 1261229 B.C. Ltd., in each case, pursuant to the terms described in a confidential exchange offer memorandum dated November 24, 2025. A copy of the Company's press release announcing the final results and expiration of the Offers is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Number Description 99.1* Press Release of Bausch Health Companies Inc., dated December 23, 2025, relating to the final results and expiration of exchange offers 101.SCH* XBRL Taxonomy Extension Schema Document 101.LAB* XBRL Taxonomy Extension Label Linkbase Document 101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document 104* Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) ____________________________________ * Filed herewith.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 23, 2025 BAUSCH HEALTH COMPANIES INC. By: /s/ Jean-Jacques Charhon Jean-Jacques Charhon Executive Vice President, Chief Financial Officer (Principal Financial Officer)